Presvu Eye Drops: Govt okays eye drops that can improve vision in 15 minutes, sales start next month

The Drug Controller General of India (DCGI) has granted approval for a new eye drop aimed at reducing the dependence on reading glasses. Mumbai-based Entod Pharmaceuticals announced the final approval for PresVu eye drops, with plans to launch the product in the domestic market in the first week of October.

First-of-its-Kind Treatment for Presbyopia

Entod Pharmaceuticals PresVu eye drop is the first eye drop in India specifically designed to address presbyopia, a common age-related vision problem that typically affects individuals over 40. The approval followed a recommendation from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO). "Presbyopia has long been treated with reading glasses, contact lenses and surgical measures. With PresVu, it can be treated effectively as the eye drop improves near vision within 15 minutes," Dr Aditya Sethi told NDTV.

Entod Pharmaceuticals Presvu Eye Drops

"This approval from the DCGI is a significant milestone in our mission to revolutionize eye care in India. Entod Pharmaceuticals PresVu eye drop is more than just a product; it's a solution that can enhance the lives of millions by providing them with greater visual independence," said Nikkhil K Masurkar, CEO of Entod Pharmaceuticals, as quoted by news agency PTI.

Global Impact and Future Plans

Presbyopia affects between 1.09 and 1.8 billion people worldwide, making it a widespread issue as people age, leading to a decreased ability to focus on nearby objects. Entod Pharmaceuticals aims to address this issue not only in India but also in emerging markets such as Africa and Southeast Asia.

Innovation and Global Strategy

"Most exports to the US are low-cost generics. We aim to change that by focusing on innovation and becoming a global leader in new developments, which we can then out-license to other countries. This is our future strategy," Entod Pharmaceuticals, Masurkar said.

(Input from PTI)